Literature DB >> 18074376

A validation study of depressive syndromes in Parkinson's disease.

Sergio E Starkstein1, Marcelo Merello, Ricardo Jorge, Simone Brockman, David Bruce, Gustavo Petracca, Robert G Robinson.   

Abstract

The validity, sensitivity, and specificity of depressive symptoms for the diagnosis of major depression, minor depression, dysthymic disorder, and subsyndromal depression in Parkinson's disease (PD) were examined. A consecutive series of 173 patients with PD attending a Movement Disorders Clinic underwent a comprehensive psychiatric and neurological assessment. The symptoms of loss of interest/pleasure, changes in appetite or weight, changes in sleep, low energy, worthlessness or inappropriate guilt, psychomotor retardation/agitation, concentration deficits, and suicide ideation were all significantly associated with the presence of the DSM-IV depressed mood criterion for major depression. The symptoms of changes in appetite, changes in sleep, low energy, low self-esteem, poor concentration, and hopelessness were all significantly associated with the presence of the DSM-IV criterion of sad mood for dysthymic disorder. Thirty percent of our sample met DSM-IV diagnostic criteria for major depression, 20% met diagnostic criteria for dysthymic disorder, 10% met diagnostic criteria for minor depression, and 8% met clinical criteria for subsyndromal depression. Patients with either major or minor depression had significantly more severe deficits in activities of daily living, more severe cognitive impairments, and more severe Parkinsonism than patients with either dysthymic disorder or no depression. This study provides validation to the DSM-IV diagnostic criteria for major depression and dysthymic disorder for use in PD. The categories of minor and subsyndromal depression may need further validation. (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Year:  2008        PMID: 18074376     DOI: 10.1002/mds.21866

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  23 in total

Review 1.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.

Authors:  Karen L Eskow Jaunarajs; Mariana Angoa-Perez; Donald M Kuhn; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2010-07-06       Impact factor: 8.989

Review 2.  A tune in "a minor" can "b major": a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults.

Authors:  Thomas W Meeks; Ipsit V Vahia; Helen Lavretsky; Ganesh Kulkarni; Dilip V Jeste
Journal:  J Affect Disord       Date:  2011-03       Impact factor: 4.839

Review 3.  Psychomotor retardation in depression: biological underpinnings, measurement, and treatment.

Authors:  Jeylan S Buyukdura; Shawn M McClintock; Paul E Croarkin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-10-31       Impact factor: 5.067

Review 4.  Depression in Parkinson's disease.

Authors:  J Schwarz; P Odin; C Buhmann; I Csoti; W Jost; U Wüllner; A Storch
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

5.  [Coexistent depressive and anxiety disorders in neurological diseases: from a perspective of multimorbidity].

Authors:  H P Kapfhammer
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

6.  Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease.

Authors:  Hae-Won Shin; Young C Youn; Sun J Chung; Young H Sohn
Journal:  J Neurol       Date:  2016-05-13       Impact factor: 4.849

Review 7.  Psychiatric symptoms in Parkinson's disease.

Authors:  Frank Schneider; Astrid Althaus; Volker Backes; Richard Dodel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

Review 8.  Neuropsychiatric symptoms in Parkinson's disease.

Authors:  Dag Aarsland; Laura Marsh; Anette Schrag
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

Review 9.  Depression and Parkinson's disease: current knowledge.

Authors:  Laura Marsh
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

10.  Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.

Authors:  Kenn Freddy Pedersen; Guido Alves; Kolbjørn Brønnick; Dag Aarsland; Ole-Bjørn Tysnes; Jan Petter Larsen
Journal:  J Neurol       Date:  2009-08-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.